NCCNN Conference Sponsors
Thank you to the following companies who have provided educational grants to make the NCCNN Conference 2017 possible:
Servier is an international pharmaceutical company, with no shareholders, governed by a non‐profit Foundation and headquartered in France. Corporate growth is driven by Servier’s constant search for innovation in five areas of excellence: cardiology, oncology, metabolism, neuropsychiatry and rheumatology, as well as by its activities in high quality generic drugs. Being completely independent, the Group reinvests 25% of Servier’s products turnover in Research and Development, and all its profits in its growth.
Merck Serono is the biopharmaceutical division of Merck, with a focus on transforming people’s lives for the better. They strive to bring breakthrough solutions to people living with cancer, multiple sclerosis, infertility, endocrine and metabolic disorders as well as cardiovascular diseases.
Norgine Pharmaceuticals Ltd is committed to developing products not only to treat life-threatening conditions but, importantly, to improve the quality of life for patients with a range of acute and chronic illnesses.Its core focus is on gastroenterology, hepatology, pain management, and incontinence.
The following companies will be also exhibiting at the conference:
The primary objective of Sirtex Medical is to research, develop, and commercialise effective treatments for liver cancer using novel small particle technology. Sirtex continuously improves upon its liver cancer treatments through a program of research and clinical studies carried out across the world.
Here at Protexin (Probiotics International Ltd), manufacturers of Bio-Kult, we are dedicated to producing innovative research-based products of the highest quality. Our unrivalled experience in manufacturing live bacteria products for over 25 years, together with quality assurance and accreditation, is second to none.